VENESSA SMITH: Open Payments
NPI 1508510181 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 25 payments from 5 companies in 2025. Trend: 2023 $118 · 2024 $156 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $361 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $190 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| PFIZER INC. | 1 | $35 |
| Lilly USA, LLC | 2 | $30 |
Products named: TREMFYA, ENTYVIO, XELJANZ, GATTEX, ZENPEP, VOWST, EOHILIA, OMVOH.
Industry payments across NY — which companies pay providers there.
